Dermata Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Dermata Therapeutics (DRMAW) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Dermata Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Dermata Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Dermata Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $41 | 4.2k | 0.01 |
2024-06-30 | $71 | 5.0k | 0.01 |
2024-03-31 | $14 | 1.5k | 0.01 |
2023-12-31 | $23 | 3.4k | 0.01 |
2023-09-30 | $100 | 5.6k | 0.02 |
2023-03-31 | $36 | 1.8k | 0.02 |
2022-12-31 | $138 | 6.9k | 0.02 |
2022-09-30 | $1.0k | 9.1k | 0.11 |
2022-03-31 | $1.0k | 3.3k | 0.31 |
2021-12-31 | $3.0k | 7.0k | 0.43 |
2021-09-30 | $2.0k | 3.0k | 0.67 |
Top funds holding Dermata Therapeutics
View all funds holding Dermata Therapeutics